Express News | Tencent HK shares open lower at 7% after the U.S. adds Tencent and others to the list of Chinese firms allegedly aiding Beijing's Military. Its ADR dropped significantly in U.S. market trading.
Hong Kong stock fluctuation | TENCENT (00700) opened down over 7%, listed on the USA Department of Defense list. The company responded that it does not affect its Business.
TENCENT Holdings (00700) opened down over 7%, and as of the time of this report, it has dropped by 7.03%, trading at 380.6 HKD, with a turnover of 3.68 billion HKD.
Selected announcement | POLY PROPERTY's contract sales for 2024 reached 54.2 billion yuan; WUXI BIO plans to sell its Ireland vaccine factory for 0.5 billion USD.
In 2024, Poly Real Estate's contracted sales exceeded 54 billion yuan; TRULY INT'L's annual operating net profit increased by over 10% year-on-year.
U.S. stock market closing: the three major Indexes had mixed results, with the Technology conference CES boosting chip stocks higher.
① Nasdaq China Golden Dragon Index closed down 1.16%, most China Concept Stocks fell, Tencent ADR dropped nearly 8%; ② MicroStrategy has purchased Bitcoin for nine consecutive weeks; ③ Trump denies plans to reduce the applicability of tariffs; ④ Qualcomm announces the launch of the new AI chip Snapdragon X.
Selected announcements from Gelonghui (Hong Kong stocks) | WUXI BIO (02269.HK) intends to sell assets related to the Irish vaccine facility for 0.5 billion US dollars.
【Today's Focus】WUXI BIO (02269.HK) plans to sell assets related to the Ireland vaccine facility for 0.5 billion USD. WUXI BIO (02269.HK) announced that on January 6, 2025, the company and WUXI HAI DE Ireland (the seller, a wholly-owned subsidiary of the company) entered into an agreement with MSD International (the buyer), according to which, subject to the terms and conditions of the agreement, the seller has conditionally agreed to sell and the buyer has conditionally agreed to purchase assets related to the Ireland vaccine facility, with a total consideration of approximately 500 million USD. The Ireland vaccine facility produces commercial products for the buyer.
Prosus Well-Placed for Sustained Growth -- Market Talk
